EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN

Luca Scarallo iD, Paolo Lionetti iD, Jaroslaw Kierkus, Lauren Collen iD, Victoria Riedl iD, Christian Jakobsen iD, Gemma Pujol-Muncunill iD, Kaija-Leena Kolho iD, Marta Velasco Rodriguez-Belvis iD, Katarina Mitrova iD, Darja Urlep, Benedicte Pigneur iD und 20 weitere

Journal of Pediatric Gastroenterology and Nutrition · 05.11.2026

DOI: 10.1002/jpn3.70645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 05.11.2026. Verfasst von Luca Scarallo und 31 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Nutrition Unit, Meyer Children's Hospital IRCCS, Florence, Italy. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to assess vedolizumab and ustekinumab efficacy and safety in patients with very‐early onset inflammatory bowel disease (VEO‐IBD).

Methods

A retrospective study involving 29 European and North American sites affiliated with the IBD Porto Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition. Clinical and laboratory data were collected from patients with VEO‐IBD who commenced vedolizumab or ustekinumab before 6 years of age, between 2014 and 2024.

Results

Ninety‐six patients (60.4% females) were included (58 ulcerative colitis, 29 Crohn's disease, and 9 IBD‐Unclassified). Median (Q1–Q3) age at diagnosis was 2.3 (0.4–4.2) years, 37 (38.5%) patients were diagnosed at age

Schlagwörter

Stichwörter der Autor:innen

Crohn's diseaseVEO‐IBDbiologic therapymonoclonal antibodiesulcerative colitis

Autor:innen und Institutionen

  • Gastroenterology and Nutrition Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, The Children's Memorial Health Institute, Warsaw, Poland.
  • Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital LMU, Munich, Germany.
  • Department of Pediatric and Adolescent Medicine, Amager-Hvidovre University Hospital, Copenhagen IBD Center, Copenhagen, Denmark.
  • Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Hospital Sant Joan de Déu, Barcelona, Spain.

ORCID-Profile: Luca Scarallo, Paolo Lionetti, Lauren Collen, Victoria Riedl, Christian Jakobsen, Gemma Pujol-Muncunill, Kaija-Leena Kolho, Marta Velasco Rodriguez-Belvis, Katarina Mitrova, Benedicte Pigneur, Seamus Hussey, Firas Rinawi, Jan De Laffolie, Karl Mårild, Anat Yerushalmy-Feler, Maya Granot, Elisabeth De Greef, Christos Tzvinikos, Christoph Norden, Kwang Yang Lee, Rémi Duclaux-Loras, Saverio Pochesci, Naire Sansotta, Dror S Shouval, Yael Weintraub

Förderung

  • None

Zitieren

APA

Scarallo, L., Lionetti, P., Kierkus, J., Collen, L., Riedl, V., Jakobsen, C., Pujol-Muncunill, G., Kolho, K. L., Velasco Rodriguez-Belvis, M., Mitrova, K., Urlep, D., Pigneur, B., Hussey, S., Rinawi, F., De Laffolie, J., Mårild, K., Yerushalmy-Feler, A., Tzion, R. L., Granot, M., …, & CEDATA Group (2026). Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70645

Vancouver

Scarallo L, Lionetti P, Kierkus J, Collen L, Riedl V, Jakobsen C, et al. Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70645

BibTeX
@article{Scarallo2026,
  author = {Scarallo, Luca and Lionetti, Paolo and Kierkus, Jaroslaw and Collen, Lauren and Riedl, Victoria and Jakobsen, Christian and Pujol-Muncunill, Gemma and Kolho, Kaija-Leena and Velasco Rodriguez-Belvis, Marta and Mitrova, Katarina and Urlep, Darja and Pigneur, Benedicte and Hussey, Seamus and Rinawi, Firas and De Laffolie, Jan and Mårild, Karl and Yerushalmy-Feler, Anat and Tzion, Raffi Lev and Granot, Maya and Aloi, Marina and De Greef, Elisabeth and Tzvinikos, Christos and Norden, Christoph and Strisciuglio, Caterina and Lee, Kwang Yang and Duclaux-Loras, Rémi and Pochesci, Saverio and Sansotta, Naire and Rohani, Pejman and Shouval, Dror S and Weintraub, Yael and CEDATA Group, CEDATA Group},
  title = {Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  doi = {10.1002/jpn3.70645}
}
Kostenlos starten →